The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Molecular Biology of Neuroblastoma
Abstract
PURPOSE AND RESULTS: Neuroblastoma, the most common solid extracranial neoplasm in children, is remarkable for its clinical heterogeneity. Complex patterns of genetic abnormalities interact to determine the clinical phenotype. The molecular biology of neuroblastoma is characterized by somatically acquired genetic events that lead to gene overexpression (oncogenes), gene inactivation (tumor suppressor genes), or alterations in gene expression. Amplification of the MYCN proto-oncogene occurs in 20% to 25% of neuroblastomas and is a reliable marker of aggressive clinical behavior. No other oncogene has been shown to be consistently mutated or overexpressed in neuroblastoma, although unbalanced translocations resulting in gain of genetic material from chromosome bands 17q23-qter have been identified in more than 50% of primary tumors. Some children have an inherited predisposition to develop neuroblastoma, but a familial neuroblastoma susceptibility gene has not yet been localized. Consistent areas of chromosomal loss, including chromosome band 1p36 in 30% to 35% of primary tumors, 11q23 in 44%, and 14q23-qter in 22%, may identify the location of neuroblastoma suppressor genes. Alterations in the expression of the neurotrophins and their receptors correlate with clinical behavior and may reflect the degree of neuroblastic differentiation before malignant transformation. Alterations in the expression of genes that regulate apoptosis also correlate with neuroblastoma behavior and may help to explain the phenomenon of spontaneous regression observed in a well-defined subset of patients. CONCLUSION: The molecular biology of neuroblastoma has led to a combined clinical and biologic risk stratification. Future advances may lead to more specific treatment strategies for children with neuroblastoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage
Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., & Bishop, J. M. (1984) · Science · doi:10.1126/science.6719137 · Cited by 2,262
Association of Multiple Copies of the N-myc Oncogene with Rapid Progression of Neuroblastomas
Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., & Hammond, D. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510313131802 · Cited by 2,010
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minty, A., Chalon, P., Lelias, J.-M., Dumont, X., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80540-1 · Cited by 1,637
Schwab, M., Alitalo, K., Klempnauer, K.-H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., & Trent, J. (1983) · Nature · doi:10.1038/305245a0 · Cited by 1,407
The trk Proto-Oncogene Product: a Signal Transducing Receptor for Nerve Growth Factor
Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V., & Parada, L. F. (1991) · Science · doi:10.1126/science.1850549 · Cited by 1,379
Biedler, J. L., Helson, L., & Spengler, B. A. (1973) · PubMed · Cited by 1,295
Targeted expression of MYCN causes neuroblastoma in transgenic mice
Weiss, W. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.2985 · Cited by 870
Transposition and amplification of oncogene-related sequences in human neuroblastomas
Kohl, N. E., Kanda, N., Schreck, R. R., Bruns, G., Latt, S. A., Gilbert, F., & Alt, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90169-1 · Cited by 731
Nakagawara, A., Arima-Nakagawara, M., Scavarda, N. J., Azar, C. G., Cantor, A. B., & Brodeur, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303253281205 · Cited by 694
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. I., & Brodeur, G. M. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.581 · Cited by 594
Neurotrophic factors and their receptors.
Barbacid, M. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80022-0 · Cited by 577
Look, A. T., Hayes, F. A., Nitschke, R., McWilliams, N. B., & Green, A. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407263110405 · Cited by 491
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda, S., Sieverts, H., Friesen, C., Herr, I., & Debatin, K. (1997) · PubMed · Cited by 482
Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development
Rosengard, A. M., Krutzsch, H. C., Shearn, A., Biggs, J. R., Barker, E., Margulies, I. M. K., King, C. R., Liotta, L. A., & Steeg, P. S. (1989) · Nature · doi:10.1038/342177a0 · Cited by 481
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with Neuroblastoma
Caron, H. N., Sluis, P. V., de Kraker, J., Bökkerink, J. P. M., Egeler, M., Laureys, G., Slater, R. M., Westerveld, A., Voûte, P. A., & Versteeg, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340404 · Cited by 425
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens, F., Johansson, B., Höglund, M., et al. (1997) · PubMed · Cited by 425
Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara, A., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.759 · Cited by 423
SPECIAL PATTERN OF WIDESPREAD NEUROBLASTOMA WITH A FAVOURABLE PROGNOSIS
D'Angio, G., Evans, A., & Koop, C. E. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91606-0 · Cited by 401
Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., & Brodeur, G. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3753 · Cited by 396
Cytogenetic features of human neuroblastomas and cell lines.
Brodeur, G. M., Green, A. A., Hayes, F. A., Williams, K. J., Williams, D. L., & Tsiatis, A. A. (1981) · PubMed · Cited by 383
Mutation and cancer: neuroblastoma and pheochromocytoma.
Knudson, A. G., & Strong, L. C. (1972) · PubMed · Cited by 341
Elongin (SIII): A Multisubunit Regulator of Elongation by RNA Polymerase II
Aso, T., Lane, W. S., Conaway, J. W., & Conaway, R. C. (1995) · Science · doi:10.1126/science.7660129 · Cited by 331
Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., & Haber, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340405 · Cited by 322
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
Schwab, M., Varmus, H. E., & Bishop, J. M. (1985) · Nature · doi:10.1038/316160a0 · Cited by 288
Grandori, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01025-6 · Cited by 285
Castle, V. P., Heidelberger, K. P., Bromberg, J., Ou, X., Dole, M. G., & Núñez, G. (1993) · PubMed · Cited by 283
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole, M. G., Núñez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A., & Castle, V. P. (1994) · PubMed · Cited by 277
Cytoplasmic Sequestration of Wild-Type p53 Protein Impairs the G 1 Checkpoint after DNA Damage
Moll, U. M., Ostermeyer, A. G., Haladay, R., Winkfield, B., Frazier, M., & Zambetti, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1126 · Cited by 277
Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells
(1991) · Springer eBooks · doi:10.1007/978-1-4615-3794-6 · Cited by 276
Infant Cancer in the U.S.: Histology-Specific Incidence and Trends, 1973 to 1992
Gurney, J. G., Ross, J. A., Wall, D. A., Bleyer, W. A., Severson, R. K., & Robison, L. L. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00004 · Cited by 276
Expression of CD44R1 adhesion molecule in colon carcinomas and metastases
Tanabe, K. K., Ellis, L. M., & Saya, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90490-8 · Cited by 271
Human neuroblastomas and abnormalities of chromosomes 1 and 17.
Gilbert, F., Feder, M., Balaban, G. B., Brangman, D., Lurie, D., Podolsky, R., Rinaldt, V., Vinikoor, N., & Weisband, J. (1984) · PubMed · Cited by 251
Marsters, S. A., Sheridan, J. P., Donahue, C. J., Pitti, R. M., Gray, C. L., Goddard, A. D., Bauer, K. D., & Ashkenazi, A. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70791-4 · Cited by 250
Kogner, P., Barbany, G., Dominici, C., Castello, M. A., Raschellà, G., & Persson, H. (1993) · PubMed · Cited by 247
Biology and Genetics of Human Neuroblastomas
Brodeur, G. M., Maris, J. M., Yamashiro, D. J., Hogarty, M. D., & White, P. S. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199703000-00001 · Cited by 236
Self-citationClinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.
Bradshaw, D. M., & Arceci, R. J. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.11.3674 · Cited by 223
Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara, A., Arima, M., Azar, C. G., Scavarda, N. J., & Brodeur, G. M. (1992) · PubMed · Cited by 219
The national cancer data base report on patterns of childhood cancers in the United States
Grovas, A., Fremgen, A., Rauck, A., Ruymann, F. B., Hutchinson, C. L., Winchester, D. P., & Menck, H. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12<2321::aid-cncr14>3.0.co;2-w · Cited by 216
Reed, J. C., Meister, L., Tanaka, S., Cuddy, M., Yum, S., Geyer, C. R., & Pleasure, D. (1991) · PubMed · Cited by 216
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Núñez, G., & Castle, V. P. (1995) · PubMed · Cited by 214
Absence of p53 gene mutations in primary neuroblastomas.
Vogan, K. J., Bernstein, M. L., Leclerc, J., Brisson, L., Brossard, J., Brodeur, G. M., Pelletier, J., & Gros, P. (1993) · PubMed · Cited by 196
Matsumoto, K., Wada, R. K., Yamashiro, J. M., Kaplan, D., & Cj, T. (1995) · PubMed · Cited by 193
Lack of High-Affinity Nerve Growth Factor Receptors in Aggressive Neuroblastomas
Suzuki, T., Bogenmann, E., Shimada, H., Stram, D., & Seeger, R. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.377 · Cited by 187
N-myc can cooperate with ras to transform normal cells in culture.
Yancopoulos, G. D., Nisen, P. D., Tesfaye, A., Kohl, N. E., Goldfarb, M. P., & Alt, F. W. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5455 · Cited by 184
Plantaz, D., Mohapatra, G., Matthay, K. K., Pellarin, M., Seeger, R. C., & Feuerstein, B. G. (1997) · Europe PMC (PubMed Central) · Cited by 181
Self-citationCaron, H. N. (1995) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950240402 · Cited by 175
Neurofibromatosis type 1 gene mutations in neuroblastoma
The, I., Murthy, A. E., Hannigan, G. E., Jacoby, L. B., Menon, A. G., Gusella, J. F., & Bernards, A. (1993) · Nature Genetics · doi:10.1038/ng0193-62 · Cited by 165
Bates, S. E., Mickley, L. A., Chen, Y. N., Richert, N., Rudick, J., Biedler, J. L., & Fojo, A. T. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.10.4337 · Cited by 163
Expression of CD44 is repressed in neuroblastoma cells.
Shtivelman, E., & Bishop, J. M. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5446 · Cited by 161
Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
Bordow, S. B., Norris, M. D., Haber, P. S., Marshall, G. M., & Haber, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3286 · Cited by 159
Takeda, O., Homma, C., Maseki, N., Sakurai, M., Kanda, N., Schwab, M., Nakamura, Y., & Kaneko, Y. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870100106 · Cited by 159
Sugiura, Y., Shimada, H., Seeger, R. C., Laug, W. E., & DeClerck, Y. A. (1998) · PubMed · Cited by 154
Johnson, M. R., Look, A. T., DeClue, J. E., Valentine, M. B., & Lowy, D. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5539 · Cited by 151
(1995) · PubMed · Cited by 150
Roy, N. V., Laureys, G., Cheng, N. C., Willem, P., Opdenakker, G., Versteeg, R., & Speleman, F. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870100205 · Cited by 150
Familial neuroblastoma. Case reports, literature review, and etiologic considerations
Kushner, B. H., Gilbert, F., & Helson, L. (1986) · Cancer · Cited by 148
Wenzel, A., Cziepluch, C., Hamann, U., Schürmann, J., & Schwab, M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04938.x · Cited by 147
Constitutional translocation t(1;17)(p36;q12–21) in a patient with neuroblastoma
Laureys, G., Speleman, F., Opdenakker, G., Benoît, Y., & Leroy, J. (1990) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870020315 · Cited by 141
Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada, M., Krajewski, S., Tanaka, S., Cazals-Hatem, D. L., Spengler, B. A., Ross, R. A., Biedler, J. L., & Reed, J. C. (1993) · PubMed · Cited by 138
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro, H., Hayashi, Y., Kawamura, M., Hayashi, K., Kaneko, Y., Kamoshita, S., Hanada, R., Yamamoto, K., Hongo, T., & Yamada, M. (1993) · PubMed · Cited by 135
Caron, H. N., Sluis, P. V., van Hoeve, M., de Kraker, J., Bras, J., Slater, R. M., Mannens, M. M. A. M., Voûte, P. A., Westerveld, A., & Versteeg, R. (1993) · Nature Genetics · doi:10.1038/ng0693-187 · Cited by 134
Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
Corvi, R., Savelyeva, L., Breit, S., et al. (1995) · PubMed · Cited by 119
Neoplastic Transformation by the Human Gene N-myc
Small, M. B., Hay, N., Schwab, M., & Bishop, J. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1638 · Cited by 117
Bader, S. A., Fasching, C. L., Brodeur, G. M., & Stanbridge, E. J. (1991) · PubMed · Cited by 114
Constitutional 1p36 deletion in a child with neuroblastoma.
Biegel, J. A., White, P. S., Marshall, H. N., Fujimori, M., Zackai, E. H., Scher, C. D., Brodeur, G. M., & Emanuel, B. S. (1993) · PubMed · Cited by 112
Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients
Łastowska, M., Cotterill, S. J., Pearson, A. D. J., Roberts, P., McGuckin, A. G., Lewis, I. J., & Bown, N. P. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00282-7 · Cited by 111
Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells.
Savelyeva, L., Corvi, R., & Schwab, M. (1994) · PubMed · Cited by 109
Zhu, Q., & M S Center (1994) · PubMed · Cited by 99
Goldman, S. C., CHEN, C.-Y., Lansing, T. J., Gilmer, T. M., & Kastan, M. (1996) · Europe PMC (PubMed Central) · Cited by 97
Deletion of chromosome 11 and of 14q sequences in neuroblastoma
Srivatsan, E. S., Ying, K. L., & Seeger, R. C. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070106 · Cited by 97
NEUROBLASTOMA AND PARENTAL OCCUPATION
Bunin, G. R., Ward, E., Kramer, S., Rhee, C., & Meadows, A. T. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115568 · Cited by 95
Posmantur, R. M., McGinnis, K., Nadimpalli, R., Gilbertsen, R. B., & Wang, K. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062328.x · Cited by 94
Lavenius, E., Gestblom, C., Johansson, I., Nånberg, E., & Påhlman, S. (1995) · PubMed · Cited by 94
Moley, J. F., Brother, M. B., Wells, S. A., Spengler, B. A., Biedler, J. L., & Brodeur, G. M. (1991) · PubMed · Cited by 93
Łastowska, M., Nacheva, E. P., McGuckin, A. G., Curtis, A., Grace, C. D., Pearson, A. D. J., & Bown, N. P. (1997) · PubMed · Cited by 90
Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn, S. L., Salwen, H. R., Quasney, M. W., Ikegaki, N., Cowan, J. M., Herst, C. V., Kennett, R. H., Rosen, S. T., DiGiuseppe, J. A., & Brodeur, G. M. (1990) · PubMed · Cited by 88
CD44 -- A New Prognostic Marker for Neuroblastoma
Favrot, M., Combaret, V., & Lasset, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312233292615 · Cited by 87
Identification of human DAN gene, mapping to the putative neuroblastoma tumor suppressor locus.
Enomoto, H., Ozaki, T., Takahashi, E., Nomura, N., Tabata, S., Takahashi, H., Ohnuma, N., Tanabe, M., Iwai, J., & Yoshida, H. (1994) · PubMed · Cited by 87
Low frequency of the p53 gene mutations in neuroblastoma
Hosoi, G., Hara, J., Okamura, T., Osugi, Y., Ishihara, S., Fukuzawa, M., Okada, A., Okada, S., & Tawa, A. (1994) · Cancer · Cited by 86
Rydén, M., Sehgal, R., Dominici, C., Fh, S., Ibáñez, C. F., & Kogner, P. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.435 · Cited by 85
Amplification of the E2F1 transcription factor gene in the HEL erythroleukemia cell line
Saito, M., Helin, K., Valentine, M. B., Griffith, B. B., Willman, C. L., Harlow, E., & Look, A. T. (1995) · Genomics · doi:10.1016/0888-7543(95)80118-6 · Cited by 84
Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
Hiyama, E., Hiyama, K., Ohtsu, K., Yamaoka, H., Ichikawa, T., Shay, J. W., & Yokoyama, T. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00226-8 · Cited by 75
Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells
Bunone, G., Mariotti, A., Compagni, A., Morandi, E., & Valle, G. D. (1997) · Oncogene · doi:10.1038/sj.onc.1200972 · Cited by 71
Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma.
Takita, J., Hayashi, Y., Kohno, T., Yamaguchi, N., Hanada, R., Yamamoto, K., & Yokota, J. (1997) · PubMed · Cited by 70
Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl‐2 expression
Hoehner, J. C., Hedborg, F., Jernberg‐Wiklund, H., Olsen, L., & Påhlman, S. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620106 · Cited by 64
The biological effects of antisense N-myc expression in human neuroblastoma.
Schmidt, M. L., Salwen, H. R., Manohar, C. F., Ikegaki, N., & Cohn, S. L. (1994) · PubMed · Cited by 55
Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma
Norris, M. D., Bordow, S. B., Haber, P., Marshall, G. M., Kavallaris, M., Madafiglio, J., Cohn, S. L., Salwen, H. R., Schmidt, M. L., Hipfner, D. R., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00284-0 · Cited by 54
Activation of trk-A but not trk-B signal transduction pathway inhibits growth of Neuroblastoma cells
Lucarelli, E., Kaplan, D. R., & Thiele, C. J. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00266-9 · Cited by 52
Human neuroblastoma cell lines that express N-myc without gene amplification
Wada, R. K., Seeger, R. C., Brodeur, G. M., Einhorn, P. A., Rayner, S. A., Tomayko, M. M., & Reynolds, C. P. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11<3346::aid-cncr2820721134>3.0.co;2-e · Cited by 51
Molecular genetic analysis of familial neuroblastoma
Maris, J. M., Kyemba, S. M., Rebbeck, T. R., White, P. S., Sulman, E. P., Jensen, S. J., Allen, C., Biegel, J. A., & Brodeur, G. M. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00265-7 · Cited by 50
Self-citationOue, T., Fukuzawa, M., Kusafuka, T., Kohmoto, Y., Imura, K., Nagahara, S., & Okada, A. (1996) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(96)90009-3 · Cited by 49
Structural organisation and chromosomal mapping of the human Id-3 gene
Deed, R. W., Hirose, T., Mitchell, E. L. D., Santibanez‐Koref, M., & Norton, J. D. (1994) · Gene · doi:10.1016/0378-1119(94)90676-9 · Cited by 48
Roy, N. V., Forus, A., Myklebost, O., Cheng, N. C., Versteeg, R., & Speleman, F. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(95)00034-m · Cited by 47
Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong, X., Choi, S. H., Inoue, A., Xu, F., Chen, T.-X., Takita, J., Yokota, J., Bessho, F., Yanagisawa, M., Hanada, R., et al. (1997) · PubMed · Cited by 47
Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma
Martinsson, T., Sjöberg, R., Hedborg, F., & Kogner, P. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00259-2 · Cited by 45
Hoehner, J., Gestblom, C., Olsen, L., & Påhlman, S. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.203 · Cited by 44
No CDKN2 mutations in neuroblastomas.
Beltinger, C. P., White, P. S., Sulman, E. P., Maris, J. M., & Brodeur, G. M. (1995) · PubMed · Cited by 44
Self-citationExpression of bcl‐2 gene product in neuroblastoma
Ramani, P., & Lu, Q. (1994) · The Journal of Pathology · doi:10.1002/path.1711720308 · Cited by 43
Bcl-2 oncoprotein expression and apoptosis in neuroblastoma
Ikeda, H., Hirato, J., Akami, M., et al. (1995) · Journal of Pediatric Surgery · doi:10.1016/0022-3468(95)90752-1 · Cited by 39
Svensson, T., Rydén, M., Schilling, F. H., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00290-6 · Cited by 39
Roy, N. V., Laureys, G., Gele, M. V., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00319-5 · Cited by 35
Telomerase expression in primary neuroblastomas
Reynolds, C. P., Zuo, J. J., Kim, N. W., Wang, H., Lukens, J. N., Matthay, K. K., & Seeger, R. C. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00287-6 · Cited by 28
Self-citationConcomitant p53 mutation and MYCN amplification in neuroblastoma
Manhani, R., Cristófani, L. M., Filho, V. O., & Bendit, I. (1997) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199709)29:3<206::aid-mpo7>3.0.co;2-h · Cited by 19
dic(4; 17)(p11;p11): A new recurrent chromosomal abnormality in chronic b-lymphoid disorders
Callet‐Bauchu, E., Rimokh, R., Tigaud, I., Pagès, J., Gazzo, S., Bastion, Y., Sebban, C., Magaud, J., Coiffier, B., & Felman, P. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199611)17:3<156::aid-gcc3>3.0.co;2-3 · Cited by 17
Role of Apoptosis in Human Neuroblastomas
Brodeur, G. M., & Castle, V. P. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-720-8_20 · Cited by 5
Cited by
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Bentires-Alj, M., Paez, J. G., David, F. S., Keilhack, H., Halmos, B., Naoki, K., Maris, J. M., Richardson, A., Bardelli, A., Sugarbaker, D. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1923 · Cited by 509
Self-citationId2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
Lasorella, A., Noseda, M., Beyna, M., & Iavarone, A. (2000) · Nature · doi:10.1038/35036504 · Cited by 497
Neuroblastoma Screening at One Year of Age
Schilling, F. H., Spix, C., Berthold, F., Erttmann, R., Fehse, N., Hero, B., Klein, G., Sander, J., Schwarz, K., Treuner, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012277 · Cited by 464
Metadata
- Authors
- Maris, J. M., & Matthay, K. K.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-07
- Volume
- 17
- Issue
- 7
- Pages
- 2264-2264
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1951128322
- Cited by
- 639
- References
- 110
- FWCI
- 19.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.